Nektar Therapeutics | search
Click here to view Nektar Therapeutics news from 60+ newspapers.
Bookmark or Share- Nektar | Home | New Pathways to Smarter Medicine | www.nektar.comOptimizing therapeutic benefit with our unparalleled expertise in polymer chemistry. More. Advancing the treatment of autoimmune disorders, chronic inflammatory conditions and cancer with novel therapies which selectively modulate the immune system. More.
- Company | Our Story | www.nektar.comOur Story. Nektar Therapeutics is a global biopharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. We apply our deep understanding of immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective ...
- Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study ...SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, today announced the initiation of its Phase 2b clinical trial evaluating rezpegaldesleukin in patients with severe to very severe alopecia areata.
- Press Releases | Nektar TherapeuticsNektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata Mar 05, 2024 Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
- Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy ...SAN FRANCISCO, Aug. 7, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that efficacy data previously generated by Eli Lilly & Company for rezpegaldesleukin (REZPEG) that ...
More
